| Dr Joan M Colfer, MD | |
|
3301 Tamiami Trail, Collier County Government Center - Building H, Naples, FL 34106-0429 | |
| (239) 252-5332 | |
| (239) 774-5653 |
| Full Name | Dr Joan M Colfer |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 3301 Tamiami Trail, Naples, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003061326 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joan M Colfer, MD Po Box 429, Naples, FL 34106-0429 Ph: (239) 252-5332 | Dr Joan M Colfer, MD 3301 Tamiami Trail, Collier County Government Center - Building H, Naples, FL 34106-0429 Ph: (239) 252-5332 |
News Archive
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
We are on the brink of being able to predict zoonotic pandemics, say public health researchers in The Lancet. However, more work will be required to turn this goal into a reality.
Melinda Sothern, PhD, CEP, Professor of Public Health and Director of Health Promotion at LSU Health Sciences Center New Orleans, will present evidence that supports relationships seen in adolescents between insulin sensitivity and fatty liver, belly fat, and total body fat and identifies additional potential early markers of insulin resistance and metabolic syndrome in healthy 7-9 year-old children, including fat in muscle cells, blood pressure, physical activity, and birth weight.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have solved the atomic structure of a unique ubiquitin ligase complex. Ubiquitin is best known for its role in protein degradation, but more recently seen as important for cell signaling, DNA repair, anti-inflammatory, and immune responses.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 4 days ago
Dr. Gary Anthony Gallo, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Collier Blvd, Naples, FL 34114 Phone: 239-354-6000 | |
Dr. Joseph Thomas Doyle, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5051 Castello Dr, Suite 12, Naples, FL 34103 Phone: 239-248-6640 Fax: 239-591-8039 |